Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

NIH funds USC team to develop a selective Alzheimer’s drug for APOE4 carriers

Backed by the combined expertise of three USC schools, scientists are developing a new drug aimed at a previously unexplored biological target in Alzheimer's disease, aided by an $8 million grant from the National Institutes of Health.

23 Sep 2025

Improving medication access in primary care with pharmacy technician support

This study examined whether adding pharmacy technicians to primary care teams relieved clinicians and nurses of medication-access tasks and improved perceptions of burden, quality of care and patient access.

23 Sep 2025

New research reassures on opioid use during pregnancy and child development

An Indiana University study brings a comprehensive new perspective to a growing body of evidence suggesting that mild to moderate use of prescribed opioid pain medications during pregnancy does not cause an increased risk for autism spectrum disorder (ASD) or attention-deficit/ hyperactivity disorder (ADHD) in children.

17 Sep 2025

Triple negative breast cancer exploits lymph node niches to block immune defense

In almost all solid tumors - i.e. cancers with a solid tissue structure - the detection of tumor cells in the lymph nodes is considered a decisive marker for the progression of the disease.

16 Sep 2025

Limited uptake of over-the-counter naloxone despite initial surge in sales

Sales of the overdose reversal medication naloxone increased after it was made available to the public without a prescription but then dipped quickly in the period following debut of over-the-counter sales, according to a new RAND study.

16 Sep 2025

CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines

CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, announces its appointment as president of EUROPACCESS, a strategic joint venture of seven pharmaceutical service providers across Europe.

From AscellaHealth, LLC. 16 Sep 2025

Caregiver personas offer insights for improving dementia medication management

Understanding the strategies and unmet needs of caregivers managing medications for people with Alzheimer's disease or related dementias may improve the lives of both caregivers and patients.

13 Sep 2025

Research reveals undisclosed active ingredients in retail mushroom products

"Magic mushroom" edibles sold at smoke shops and convenience stores are likely to contain no psilocybin but instead a range of undisclosed active ingredients, a study led by an Oregon State University College of Pharmacy scientist shows.

13 Sep 2025

Mediterranean-style diet benefits maternal health during pregnancy and breastfeeding

A Mediterranean-style diet, rich in fiber, vegetable proteins and healthy fats, benefits maternal health during pregnancy and breastfeeding.

10 Sep 2025

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Discover how real-time Raman monitoring enhances API control and quality during hot melt extrusion.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 10 Sep 2025

New technique used to conduct real-time measurement of boron in live tumor cells

A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumors in some cancers.

10 Sep 2025

RFK Jr. said ‘everybody can get’ a covid vaccine. Is that true?

When health secretary Robert F. Kennedy Jr. testified before the Senate Finance Committee on Sept. 4, several senators criticized him for restricting the covid-19 shots after promising in November he wouldn't “take away anybody's vaccines.”

10 Sep 2025

Bee-sting inspired microneedle patches offer pain-free drug delivery

Neurological diseases affect millions worldwide, and the need for long-term patient-friendly treatments has never been greater.

10 Sep 2025

New Center for SUNSHINE aims to build aging resilience

America's population is the oldest it has ever been. And though older people are more independent than ever, they face a huge care gap, one that challenges families, communities and healthcare systems.

9 Sep 2025

As insurers struggle with GLP-1 drug costs, some seek to wean patients off

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April.

4 Sep 2025

At CDC, worries mount that agency has taken anti-science turn

Public health and access to lifesaving vaccines are on the line in a high-stakes leadership battle at the Centers for Disease Control and Prevention.

3 Sep 2025

Many pharmacies still do not stock buprenorphine despite eased prescribing rules

Faced with a worsening drug crisis, policymakers in recent years have made it much easier for doctors to prescribe the highly effective opioid addiction treatment buprenorphine.

2 Sep 2025

Medicaid expansion boosts access to opioid use disorder treatment

Medicaid plays a key role for giving people with opioid-use disorder access to treatment, according to a Rutgers Health study.

2 Sep 2025

Fluorine-containing medicines do not increase adverse drug reactions

Medicines containing a type of PFAS or 'forever chemical' called fluorine are not leading to higher numbers of adverse drug reactions according to new data analysis.

2 Sep 2025

Azelastine nasal spray significantly reduces SARS-CoV-2 infections in clinical trial

The trial, led by Professor Robert Bals, Director of the Department of Internal Medicine V at Saarland University Medical Center and Professor of Internal Medicine at Saarland University, divided the 450 participants into two groups.

2 Sep 2025